SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp, apparently newsless XCN spike is driving attention, with traders debating whether it is a fleeting pump-and-dump or a rebound worth buying. Some point to Bitcoin turning green and bullish chart patterns, while others cite XCNs history of quick spikes followed by drops.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Attention centers on reports that Papa Johns largest U.S. franchisee has joined Irth Capitals effort to take the company private. Traders are hopeful a deal could materialize, but uncertainty over the boards response and whether the bid will close remains a point of debate.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Uniteds quarterly results and weaker profit outlook are drawing attention: elevated jet-fuel costs are squeezing margins despite strong revenue and travel demand. Traders are split between viewing the demand and pricing strength as supportive and worrying that fuel expenses will keep weighing on earnings.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is drawing attention amid volatile oil prices and Middle East supply concerns, especially disruptions and uncertainty around the Strait of Hormuz and Iran negotiations. Bulls see elevated crude and the companys production growth as supportive, while skeptics point to peace-deal headlines, inventory concerns, and the stocks uneven response to oil moves.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharply reduced third-quarter outlook, tied to price cuts on distributor-held inventory and weak demand, is driving concern about the companys earnings, debt burden and potential financial distress. Bears fear further deterioration, while bulls argue the reset is largely one-time and point to debt-reduction efforts and a possible longer-term turnaround.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is drawing attention after early Phase 1 azer-cel results in progressive MS showed encouraging safety and disability-stability signals, though traders note the small, uncontrolled study and debate the muted share-price response. Discussion also highlights BRIUMVIs longer-term data and simpler dosing as support for its commercial growth story.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is drawing attention over Phase 3 results for its partnered Moderna melanoma vaccine, which reduced the risk of recurrence or death when added to Keytruda. Traders are weighing the clinically positive data and potential to support Keytruda against high expectations, uncertain commercial prospects and a sell-the-news reaction.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Newly published NEST Phase 2 results for Agenuss BOT+BAL immunotherapy in colorectal cancer are drawing attention, with traders highlighting tumor responses and no observed recurrences. Bulls see encouraging evidence for treatment before surgery, while skeptics stress the small, nonrandomized study and question the path to Phase 3 amid dilution and execution concerns.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

Discussion centers on volatile Dow and broader-market moves amid rising Treasury yields, hawkish Fed concerns, and oil and geopolitical risks tied to Iran. Traders are divided between warnings of a deeper selloff and bullish calls for a rebound, with some noting the Dows relative strength versus tech-heavy indexes.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

OXLC is drawing attention amid a sharp selloff and concerns about weaker Core NII and further NAV losses ahead of earnings, with traders pointing to prospectus information and risks in the CLO and lower-quality credit markets. The debate centers on whether the high distribution and potential recovery make the decline a buying opportunity or whether continued NAV erosion and past dividend cuts outweigh the income.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

S&P 500 Health Care ETF (RSPH) Touches New 52-Week High  

 RSPH hits a new 52-week high, rising 29.5% from its low as resilient healthcare demand, solid earnings and defensive-sector appeal fuel momentum. 

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight Health Care ETF

Retail Raves About IQVIA Holdings After Firm Raises Revenue, Profit Guidance

Equity

Bearish Sentiment

IQVIA Holdings Inc, on Monday, reported an upbeat set of earnings that topped Wall Street estimates while also raising its revenue and earnings per share (EPS) guidance for 2024. Following the announcement, shares of the firm jumped nearly 7% and retail sentiment entered extremely bullish territory (76/100) from a neutral zone supported by extremely high message volumes.<figure class="image"><img style="aspect-ratio:795/228;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_22_at_3_09_52_PM_e9a57ca2e1.png" alt="Retail sentiment trends in extremely bullish territory for IQVIA Holdings" width="795" height="228"><figcaption>Retail sentiment trends in extremely bullish territory for IQVIA Holdings</figcaption></figure>The firm, which provides advanced analytics, technology solutions, and clinical research services to the life sciences industry, reported a 2.30% year-over-year (YoY) rise in its second quarter revenue at $3.81 billion which stood higher than a Street estimate of $3.79 billion. Net income rose 22% YoY to $363 million during the quarter. The firm reported an adjusted diluted EPS of $2.64 as compared to a Street estimate of $2.57.IQVIA Holdings pointed out that as of June 30, 2024, Research &amp; Development Solutions (R&amp;DS) contracted backlog (including reimbursed expenses), stood at $30.60 billion–growing 7.70% year-over-year and 8.10% at constant currency. The company said it expects approximately $7.80 billion of this backlog to convert to revenue in the next twelve months.Ari Bousbib, chairman and CEO of IQVIA said the firm delivered second quarter results at the high-end of its guidance, driven mainly by better-than-expected Technology &amp; Analytics Solutions (TAS) performance. TAS revenue came in at $1.49 billion, registering an increase of 2.70% on a reported basis and 3.80% on a constant currency basis.The company has updated its full-year 2024 guidance for revenue to be between $15.43 billion and $15.53 billion, as compared to an earlier guidance of $15.33-15.58 billion. Adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) is expected between $3.71 billion and $3.77 billion, compared with an earlier guidance of $3.70-3.80. Adjusted diluted EPS is estimated between $11.10 and $11.30 compared with an earlier guidance of $10.95-11.25.One Stocktwits user named ‘Wigglyick’ has expressed optimism on the technical pattern formed by the stock, which other users cited as evidence of its improving fundamental picture.<figure class="image"><a href="https://stocktwits.com/Wigglyick"><img style="aspect-ratio:784/612;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_22_at_3_11_34_PM_d36f6ac6b2.png" alt="Stocktwits user Wigglyick's post on IQVIA Holdings" width="784" height="612"></a><figcaption>Stocktwits user Wigglyick's post on IQVIA Holdings</figcaption></figure> &nbsp;

IQVIA Holdings has updated its full-year 2024 guidance for revenue to be between $15.43 billion and $15.53 billion, as compared to an earlier guidance of $15.33-$15.58 billion. 

IQVIA Holdings has updated its full-year 2024 guidance for revenue to be between $15.43 billion and $15.53 billion, as compared to an earlier guidance of $15.33-$15.58 billion. Retail sentiment entered extremely bullish territory (77/100) from a neutral zone supported by extremely high message volumes.

First Trust Exchange-Traded Fund II - First Trust Nasdaq Lux Digital Health Solutions ETF

First Trust Exchange-Traded Fund III - First Trust Health Care AlphaDEX Fund

IQVIA Holdings Inc

Invesco Bloomberg Pricing Power ETF

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Mid-Cap Growth ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

RSPH News